PCK 3.57% 2.7¢ painchek ltd

PCK Chart, page-33

  1. 264 Posts.
    lightbulb Created with Sketch. 258
    Positive feedback for PainChek®
    InfantPainChek has conducted the first stage of market research with first-time parents of children below one year of age in Australia. The feedback was very positive in terms of product need and potential uptake of the PainChek® Infant technology for this parental group.A second round of quantitative market testing is set to be conducted in the coming months, followed by a first stage, targeted, direct-to-consumer market entry in Australia during the final quarter of 2023.

    As we enter the final Quarter, Im excited to see this released and it will be interesting to see the uptake.
    I’m not sure how it will be marketed, as a post clinical tool, or all round “new born must have”.
    If it takes off, watch the SP rocket. Could be a giant Christmas gift for all current holders. Nice if it happens this month with a lead up to Christmas. Just another feather in the cap.
    Cheers Holders DYOR.
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
-0.001(3.57%)
Mkt cap ! $44.16M
Open High Low Value Volume
2.8¢ 2.8¢ 2.7¢ $55.36K 1.977M

Buyers (Bids)

No. Vol. Price($)
3 219510 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 91030 1
View Market Depth
Last trade - 15.56pm 28/06/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.